CA2581001C - Kunitz-type recombinant inhibitor - Google Patents

Kunitz-type recombinant inhibitor Download PDF

Info

Publication number
CA2581001C
CA2581001C CA2581001A CA2581001A CA2581001C CA 2581001 C CA2581001 C CA 2581001C CA 2581001 A CA2581001 A CA 2581001A CA 2581001 A CA2581001 A CA 2581001A CA 2581001 C CA2581001 C CA 2581001C
Authority
CA
Canada
Prior art keywords
polypeptide
subject
composition
cells
decreasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2581001A
Other languages
English (en)
French (fr)
Other versions
CA2581001A1 (en
Inventor
Durvanei Augusto Maria
Isabel De Fatima Correia Batista
Paulo Lee Ho
Ana Marisa Chudzinski-Tavassi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNIAO QUIMICA FARMACEUTICA NACIONAL S/A
Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP
Original Assignee
UNIAO QUIMICA FARMACEUTICA NACIONAL S/A
Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNIAO QUIMICA FARMACEUTICA NACIONAL S/A, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP filed Critical UNIAO QUIMICA FARMACEUTICA NACIONAL S/A
Publication of CA2581001A1 publication Critical patent/CA2581001A1/en
Application granted granted Critical
Publication of CA2581001C publication Critical patent/CA2581001C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Insects & Arthropods (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
CA2581001A 2004-09-15 2005-09-15 Kunitz-type recombinant inhibitor Expired - Lifetime CA2581001C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BRPI0406057-1A BRPI0406057B1 (pt) 2004-09-15 2004-09-15 Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
BRPI0406057-1 2004-09-15
PCT/BR2005/000185 WO2006029492A1 (en) 2004-09-15 2005-09-15 Kunitz-type recombinant inhibitor.

Publications (2)

Publication Number Publication Date
CA2581001A1 CA2581001A1 (en) 2006-03-23
CA2581001C true CA2581001C (en) 2011-05-03

Family

ID=36273230

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2581001A Expired - Lifetime CA2581001C (en) 2004-09-15 2005-09-15 Kunitz-type recombinant inhibitor
CA002680759A Abandoned CA2680759A1 (en) 2004-09-15 2008-03-14 Kunitz-type recombinant inhibitor

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002680759A Abandoned CA2680759A1 (en) 2004-09-15 2008-03-14 Kunitz-type recombinant inhibitor

Country Status (10)

Country Link
US (1) US8440795B2 (enExample)
EP (1) EP1799707B1 (enExample)
JP (1) JP4980220B2 (enExample)
CN (1) CN101142232B (enExample)
AU (1) AU2005284615B2 (enExample)
BR (1) BRPI0406057B1 (enExample)
CA (2) CA2581001C (enExample)
DK (1) DK1799707T3 (enExample)
ES (1) ES2410160T3 (enExample)
WO (1) WO2006029492A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008109976A1 (en) * 2007-03-14 2008-09-18 União Química Farmacêutica Nacional S/A Kunitz-type recombinant inhibitor
BRPI0406057B1 (pt) 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante
NZ593815A (en) 2008-12-19 2013-05-31 Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use
US8772238B2 (en) 2009-03-18 2014-07-08 The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer
BR102018074043A2 (pt) * 2018-11-22 2020-06-02 Inst Butantan composto para a modulação de vias de rlr, tlr, oas e/ou oncostatina m, uso do mesmo para a preparação de um medicamento, composição e método para modulação das ditas vias
BR102018074037A2 (pt) * 2018-11-22 2021-05-11 Inst Butantan composto para direcionar entidades moleculares para o domínio intracelular de células neoplásicas, ingrediente farmacêutico ativo compreendendo o referido composto, composição farmacêutica, método para o diagnóstico, prognóstico e/ou tratamento de câncer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006207C2 (de) * 1980-02-15 1982-10-21 Siemens AG, 1000 Berlin und 8000 München Elektrische Maschine mit einem Ständerblechpaket aus kornorientierten Blechen
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
BRPI0406057B1 (pt) 2004-09-15 2021-10-26 União Química Farmacêutica Nacional S/A Sequência nucleotídica de um inibidor de proteases do tipo kunitz obtida a partir de uma biblioteca de cdna de glândulas salivarares de carrapatos amblyomma cajennese uso da proteína recombinante

Also Published As

Publication number Publication date
BRPI0406057B1 (pt) 2021-10-26
US20090042786A1 (en) 2009-02-12
ES2410160T3 (es) 2013-07-01
WO2006029492A1 (en) 2006-03-23
DK1799707T3 (da) 2013-05-21
CN101142232A (zh) 2008-03-12
BRPI0406057A (pt) 2006-05-02
JP2008512992A (ja) 2008-05-01
AU2005284615A1 (en) 2006-03-23
JP4980220B2 (ja) 2012-07-18
US8440795B2 (en) 2013-05-14
CA2680759A1 (en) 2008-09-18
AU2005284615B2 (en) 2011-03-31
EP1799707A1 (en) 2007-06-27
CA2581001A1 (en) 2006-03-23
EP1799707B1 (en) 2013-03-27
CN101142232B (zh) 2013-03-13

Similar Documents

Publication Publication Date Title
US6689582B1 (en) Polynucleotide molecules encoding proteins having proteinase inhibitor activity
Mende et al. Dipetalogastin, a potent thrombin inhibitor from the blood‐sucking insectDipetalogaster maximus: cDNA cloning, expression and characterization
US8440795B2 (en) Kunitz-type recombinant inhibitor
Huber-Lang et al. Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions
JPH0584083A (ja) 新規ポリペプチド、それをコードする新規ｄｎａ、新規ポリペプチドの製造方法、新規医薬組成物、および新規酵素阻害方法
EP2231702A1 (en) Protease inhibitor
Lukas et al. Hirudins of the Asian medicinal leech, Hirudinaria manillensis: same same, but different
Ranasinghe et al. A novel coagulation inhibitor from Schistosoma japonicum
Kaiserman et al. Mechanisms of serpin dysfunction in disease
Sun et al. Purification, cloning and characterization of a metalloproteinase from Naja atra venom
WO2008109976A1 (en) Kunitz-type recombinant inhibitor
WO2007101602A9 (en) Chimeric kunitz domains and their use
Hakim et al. Discoveries of serine protease inhibitors from scorpions
KR20060010740A (ko) 프로테아제 억제 단백질 및 그 이용
CN110945020B (zh) 重组蛋白及其片段、生产所述重组蛋白的方法、合成基因以及重组蛋白的用途
Debowski Natural proteinaceous inhibitors of serine proteases
WO2006112451A1 (ja) プロテインｃインヒビターを含有する抗癌剤
Monti Von Willebrand factor, ADAMTS13 and neutrophil extracellular traps: allies in cancer-associated thrombosis and tumor progression
CN106928334A (zh) 约安巨马陆抗血栓肽Joannsin及其应用
TW200846356A (en) Preparation and use of variants of the kunitz domain 2 of the human placental bikunin gene
KR101374194B1 (ko) 대하로부터 분리한 쿠니츠형 세린 프로테아제 저해인자
Woo et al. MOLECULAR STRUCTURE OF PLASMA PROTEASE INHIBITOR GENES IN MAN¹
Gonzalez-Gonzalez The trypsin inhibitor panulirin regulates
HK40026244B (zh) 重组蛋白及其片段、生产所述重组蛋白的方法、合成基因以及重组蛋白的用途
Gaspar Biochemical Investigations into Anticoagulants in Salivary Glands of the Tick Ornithodoros sa Vignyi Audouin (1827)

Legal Events

Date Code Title Description
EEER Examination request